Edward Mckenzie-Boyle’s Post

What defines the Borer Medical Team? It’s simple: exceptional understanding of each other and where we want to be. 🤝✨ It's a promise to ourselves and our clients. To foster this team spirit, Borer Medical hosts an annual multi-day team-building event. We engage in discussions, learn from each other, collaborate, promote international exchange, and, of course, ensure there's plenty of fun. 🌍🎉 📸🏞️ Take a look at our short recap of this year's Borer Medical team-building event! #TeamBorer #reprocessing #CSSD #valuepreservation #medicalinstruments #passivation #derouging #cleaningprocess

The SickKids Industry Partnerships & Commercialization (IP&C) office helps fast-track promising scientific and clinical #SKResearch discoveries into real-world applications. Watch the video below to learn more about IP&C! ⤵️ 

With Rod Raphael, MA, CCRC at SOS Save Our Sites I have known this man for about 15 years and his understanding of the clinical research site ownership game is one of the best hands down! Catch the FULL interview here and make sure you connect with Rod!

Team stability: A key ingredient in clinical trial success. Ensuring smooth sailing in clinical trials isn't just about protocols and procedures—it's about the people behind the scenes. 💪🏻 Check out this insightful article on the vital role of team stability in advancing clinical trials by Atlantic Research Group. From fostering collaboration to maintaining consistency, learn why a stable team is the cornerstone of successful trials. Dive into the full article here: https://bit.ly/4bUnBdT #ClinicalTrials #TeamStability #ResearchExcellence #HealthcareInnovation

Our effort to provide care to cleft patients around the world is based around locally staffed, permanent teams. This approach has many advantages: 1. No cultural and language barriers for patients 2. Cost efficiency due to the use of local infrastructure and reduction of travel costs 3. Reliable availability of follow-up care and the possibility of arranging and providing follow-up therapy through fixed points of contact. 4. Accumulation of medical and organizational skill and experience in the country or region where it is needed.

India stands as the most sought-after destination for cardiac procedures, attracting patients from across the globe. Renowned for its exceptional healthcare infrastructure, India offers a unique blend of expertise, affordability, and personalized care that sets it apart. With world-class hospitals equipped with state-of-the-art technology, patients can access top-tier cardiac treatments delivered by highly skilled medical professionals. The expertise of Indian cardiac surgeons, many of whom have trained internationally, ensures the highest standards of care and surgical precision. Moreover, India's cost-effective healthcare solutions make advanced cardiac procedures accessible to a broader demographic, without compromising on quality. Patients benefit from minimal waiting times, allowing for timely intervention and recovery. Additionally, India's commitment to holistic healing, integrating conventional medicine with traditional practices like Ayurveda and Yoga, promotes comprehensive well-being. Beyond medical treatment, India's rich cultural heritage and tourist attractions offer patients and their families a conducive environment for recuperation. Overall, India's reputation as a hub for cardiac care stems from its unwavering dedication to excellence, affordability, and compassionate patient-centric approach. To learn more about cardiac care in India and explore treatment options, Read our blog: https://lnkd.in/gp2mpxUp #cardiacexcellence #cardiacprocedure #heartsurgery #Indianhealthcare

Over the last 2 years the members of Consumer Voices in Clinical Trials NSW (ConVICTioN) have worked tirelessly with Janelle Bowden, Joan Torony, Angela Todd, Anthony Brown, Alex Stephens and I to create resources for consumers about clinical trials in NSW. Successful recruitment of consumers is a major challenge for clinical trials, with anecdotal evidence indicating 60% of trials in Australia recruit the target number of consumers they are seeking and only 20% meet their recruitment timeline. The resources developed by ConVICTioN can be used to educate consumers and communities about clinical trials. It has been a joy to work alongside a team of passionate consumers who want to educate consumers and communities about clinical trials Grace White, Brian F Dalton, Vanessa Yenson (PhD), Brad Rossiter OAM, Garth Hungerford, David Napier, ♥️Nadine El-Kabbout🧠, co-chaired by Sonia Dixon and Kate Rycroft with funding from the Clinical Innovation and Research Division, NSW Ministry of Health Tara Dimopoulos-Bick Anne O'Neill Jean-Frederic Levesque Kim Sutherland Please share these resources for consumers, co-designed by consumers for consumers through your networks. We are also looking for further funding to continue the work of this network and create a clinical trials consumer champions program, so please message me or Janelle Bowden if you want to explore possibilities https://lnkd.in/grTBPF8f #Nothing about us without us #Clinical trials #Consumers in clinical trials

Grateful for the glowing testimonial! Our commitment to excellence drives our services. 🙏 #LegalSupport #EfficiencyMatters #ClientAppreciation #LegalServices #LexProcessSuccess #QualityWork #Teamwork #Gratitude #LegalPartnership #ClientTestimonial #PersonalInjuryClaims #MedicalRecordsEvidence #InjuryDocumentation #LegalHealthcare #MedicalEvidence #InjuryLitigation

I'm thrilled to announce that I have joined the Journeys Metabolic team! I've said for many years that I am on a mission to "change the weight of the world." As part of this mission, I founded Heartland Weight Loss; the first insurance-based Obesity Medicine clinic in the Greater Kansas City area. Over the past five years, we have seen phenomenal growth, primarily driven by referrals from amazing clinicians in the area. In 2022, I opened a second location in Lawrence, Kansas (hiring Maribeth Orr, D.O., DABFM, DABOM to anchor that space). Again - success. The world clearly needs (and wants) brick-and-mortar Obesity Medicine clinics! However, scaling an in-person model bigger and bigger simply isn't my cup of tea - nor is it an effective way to bring evidence-based therapies to the masses. With the recent explosion of interest in this field, I have had multiple offers to partner with technology companies. I've never been opposed to the idea - it's a great way to effectively disseminate ten years of knowledge/experience to a bigger audience. Sadly, most of these tech startups are on a mission to either capitalize upon prescribing GLP-1 agonists to as many people as possible and/or promote the outdated, unscientific narrative of "eat-less, move-more" combined with some sort of motivational tool to help people embrace the misery that narrative creates. When I was approached by Journeys Metabolic and dug into their product, it was immediately clear that the leadership of this company gets it. The entire mission of the program is to help patients with metabolic health by focusing on repairing the underlying pathology that happens upstream (at the cellular level), which will inevitably have an impact downstream - improving all sorts of cardiometabolic diseases - including obesity. With a mission grounded in people and results (NOT prescriptions and profits) and a leadership team passionate about metabolic health, I couldn't NOT be a part of this company! I believe Journeys has what it takes to turn this epidemic of chronic disease around - at scale. I'm excited to see what happens as we explode into the marketplace in 2024!

No trial is too complex for us. ✨ Our team becomes part of your team so the experts that win your business are responsible for keeping your business. Always. But don't just take our word for it, ask our partners: "Our trials are quite complex…Several patients are international, so it is no small accomplishment to get the labs to us in time for appropriate safety and #efficacy monitoring. We simply could not carry out our studies without the remarkable dedication and professionalism of Firma.” #GuidingClinicalTrialsHome ➡️ https://lnkd.in/eUgbzfv